Oleoyl-estrone treatment affects the ponderostat setting differently in lean and obese Zucker rats.

PubWeight™: 0.79‹?›

🔗 View Article (PMID 10340814)

Published in Int J Obes Relat Metab Disord on April 01, 1999

Authors

C Adán1, C Cabot, R Vilà, M M Grasa, R M Masanés, M Esteve, J Estruch, J A Fernández-López, X Remesar, M Alemany

Author Affiliations

1: Departament de Bioquímica i Biologia Molecular, Facultat de Biologia, Universitat de Barcelona, Spain.

Articles by these authors

Thiopurine methyl-transferase activity and azathioprine metabolite concentrations do not predict clinical outcome in thiopurine-treated inflammatory bowel disease patients. Aliment Pharmacol Ther (2011) 3.16

Liver dysfunction related to hepatitis B and C in patients with inflammatory bowel disease treated with immunosuppressive therapy. Gut (2010) 2.98

[Analysis of quality and contents of the report of hospital discharge]. Med Clin (Barc) (1993) 2.62

Accuracy of an enzyme immunoassay for the detection of Helicobacter pylori in stool specimens in the diagnosis of infection and posttreatment check-up. Am J Gastroenterol (2000) 2.32

Incidence of collagenous and lymphocytic colitis: a 5-year population-based study. Am J Gastroenterol (1999) 2.32

Comparison of heparin and steroids in the treatment of moderate and severe ulcerative colitis. Gastroenterology (2000) 2.22

A prospective study of recurrent febrile seizures. N Engl J Med (1992) 1.99

Safety of thiopurines and anti-TNF-α drugs during pregnancy in patients with inflammatory bowel disease. Am J Gastroenterol (2013) 1.74

The risk of seizure recurrence after a first unprovoked afebrile seizure in childhood: an extended follow-up. Pediatrics (1996) 1.65

Discontinuing antiepileptic drugs in children with epilepsy: a prospective study. Ann Neurol (1994) 1.63

Effect of total enteral nutrition on the short-term outcome of severely malnourished cirrhotics. A randomized controlled trial. Gastroenterology (1990) 1.59

[Impact of control measures on the course of an outbreak of methicillin-resistant Staphylococcus aureus]. Med Clin (Barc) (1997) 1.46

Randomised clinical trial: colestyramine vs. hydroxypropyl cellulose in patients with functional chronic watery diarrhoea. Aliment Pharmacol Ther (2015) 1.41

[The evidence of human immunodeficiency virus infection in the seronegative subjects of high-risk groups]. Med Clin (Barc) (1991) 1.40

[Serotonin syndrome in acute poisoning with antidepressive agents]. Ann Fr Anesth Reanim (1996) 1.39

["Liquid ecstasy" (GHB): a recreational drug? Bio-psycho-social clinical profile of the consumer and some therapeutic proposals]. Aten Primaria (2004) 1.38

[Sociologic overview of quality life]. Med Clin (Barc) (2000) 1.38

[Quality of life: something more than a fashion]. Med Clin (Barc) (1993) 1.38

Activity of E-3846, a new fluoroquinolone, in vitro and in experimental cystitis and pyelonephritis in rats. Antimicrob Agents Chemother (1988) 1.37

Vitamin status in patients with inflammatory bowel disease. Am J Gastroenterol (1989) 1.27

In whom does status epilepticus occur: age-related differences in children. Epilepsia (1997) 1.26

In vitro antibacterial activity of irloxacin (E-3432) on clinical isolates. Drugs Exp Clin Res (1987) 1.17

Review article: prevention and management of hepatitis B and C infection in patients with inflammatory bowel disease. Aliment Pharmacol Ther (2011) 1.15

Alteration of endothelial cell monolayer integrity triggers resynthesis of vascular endothelium cadherin. J Biol Chem (1998) 1.12

Induction of acetylcholinesterase expression during apoptosis in various cell types. Cell Death Differ (2002) 1.10

Inhibition of in vitro angiogenesis by platelet factor-4-derived peptides and mechanism of action. Blood (1999) 1.09

Changes of the mucosal n3 and n6 fatty acid status occur early in the colorectal adenoma-carcinoma sequence. Gut (1996) 1.08

Fat composition may be a clue to explain the primary therapeutic effect of enteral nutrition in Crohn's disease: results of a double blind randomised multicentre European trial. Gut (2002) 1.07

Polymeric enteral diets as primary treatment of active Crohn's disease: a prospective steroid controlled trial. Gut (1993) 1.06

In vitro and in vivo antibacterial activities of E-4497, a new 3-amine-3-methyl-azetidinyl tricyclic fluoroquinolone. Antimicrob Agents Chemother (1991) 1.04

A method for the simultaneous determination of total carbohydrate and glycerol in biological samples with the anthrone reagent. J Biochem Biophys Methods (1981) 1.02

Bile acid malabsorption in microscopic colitis and in previously unexplained functional chronic diarrhea. Dig Dis Sci (2001) 1.01

In vitro and in vivo antibacterial activities of E-4868, a new fluoroquinolone with a 7-azetidin ring substituent. Antimicrob Agents Chemother (1993) 1.00

Hepatic uptake of amino acids at mid-lactation in the rat. Biochem J (1987) 0.99

Risk factors for opportunistic infections in infliximab-treated patients: the importance of screening in prevention. Eur J Clin Microbiol Infect Dis (2008) 0.98

Posterior fixation of subaxial cervical spine fractures in patients with ankylosing spondylitis. Eur Spine J (2004) 0.98

The prevalence of coeliac disease is significantly higher in children compared with adults. Aliment Pharmacol Ther (2010) 0.98

Alanine uptake by liver at midpregnancy in rats. Am J Physiol (1987) 0.97

In vitro antibacterial activity of E-3604, a new 6-fluoroquinolone, on clinical isolates. Drugs Exp Clin Res (1987) 0.97

Comparative in vitro and in vivo activities of six new monofluoroquinolone and difluoroquinolone 3-carboxylic acids with a 7-azetidin ring substituent. Antimicrob Agents Chemother (1990) 0.96

Diagnostic value of duodenal antitissue transglutaminase antibodies in gluten-sensitive enteropathy. Aliment Pharmacol Ther (2008) 0.95

Serum selenium and risk of large size colorectal adenomas in a geographical area with a low selenium status. Am J Gastroenterol (2002) 0.95

Technical note: Measurement of total estrone content in foods. Application to dairy products. J Dairy Sci (2004) 0.95

Endoscopic treatment with self-expanding metal stents for Crohn’s disease strictures. Aliment Pharmacol Ther (2012) 0.94

Clinical benefit of glycoprotein IIb/IIIa blockade with Abciximab is independent of gender: pooled analysis from EPIC, EPILOG and EPISTENT trials. Evaluation of 7E3 for the Prevention of Ischemic Complications. Evaluation in Percutaneous Transluminal Coronary Angioplasty to Improve Long-Term Outcome with Abciximab GP IIb/IIIa blockade. Evaluation of Platelet IIb/IIIa Inhibitor for Stent. J Am Coll Cardiol (2000) 0.93

Effect of oral oleoyl-estrone on adipose tissue composition in male rats. Int J Obes Relat Metab Disord (2002) 0.93

Routine tests of renal function, alcoholism, and nutrition improve the prognostic accuracy of Child-Pugh score in nonbleeding advanced cirrhotics. Am J Gastroenterol (1993) 0.93

Posterior atlanto-axial fusion with the Olerud Cervical Fixation System for odontoid fractures and C1-C2 instability in rheumatoid arthritis. Eur Spine J (2002) 0.92

High-performance liquid chromatographic screening of chlorophyll derivatives produced during fruit storage. J Chromatogr A (2000) 0.92

Energy intake of rats fed a cafeteria diet. Physiol Behav (1989) 0.92

Formaldehyde derived from dietary aspartame binds to tissue components in vivo. Life Sci (1998) 0.91

New insights into the negative regulation of hematopoiesis by chemokine platelet factor 4 and related peptides. Blood (1998) 0.91

Multicenter double-blind trial of gabexate mesylate (FOY) in unselected patients with acute pancreatitis. Digestion (1992) 0.90

Hypertransaminasemia in pediatric celiac disease patients and its prevalence as a diagnostic clue. Am J Gastroenterol (2002) 0.90

Smoking does influence disease behaviour and impacts the need for therapy in Crohn's disease in the biologic era. Aliment Pharmacol Ther (2013) 0.89

Combined effects of oral oleoyl-estrone and limited food intake on body composition of young overweight male rats. Int J Obes (Lond) (2006) 0.88

Glutamine synthetase activity in the organs of fed and 24-hours fasted rats. Horm Metab Res (1981) 0.88

Daily oral oleoyl-estrone gavage induces a dose-dependent loss of fat in Wistar rats. Obes Res (2001) 0.88

Factors related to the plasma fatty acid profile in healthy subjects, with special reference to antioxidant micronutrient status: a multivariate analysis. Am J Clin Nutr (1992) 0.87

Antineutrophil antibodies associated with ulcerative colitis interact with the antigen(s) during the process of apoptosis. Gut (2000) 0.87

Effects of chronic ethanol consumption on lactational performance in rat: mammary gland and milk composition and pups' growth and metabolism. Pharmacol Biochem Behav (1987) 0.87

Metabolic effects of short term food deprivation in the rat. Horm Metab Res (1981) 0.87

Plasma amino acids of lean and obese Zucker rats subjected to a cafeteria diet after weaning. Biochem Int (1991) 0.86

[Bilateral tension pneumothorax after retrieval of transtracheal jet ventilation catheter]. Ann Fr Anesth Reanim (2006) 0.86

L-alanine transport in small intestine brush-border membrane vesicles of obese rats. Biochim Biophys Acta (1994) 0.86

Amino acid and glucose uptake by rat brown adipose tissue. Effect of cold-exposure and acclimation. Biochem J (1988) 0.85

Intestinal handling of a glucose gavage by the rat. Mol Cell Biochem (1992) 0.85

Hind leg heat balance in obese Zucker rats during exercise. Pflugers Arch (1998) 0.85

Hypercalcemic crisis in gallbladder cancer. Acta Gastroenterol Belg (1987) 0.85

Plasma amino acid concentrations in pregnant rats and in 21-day foetuses. Biochem J (1977) 0.85

L-lactate uptake by rat liver. Effect of food deprivation and substrate availability. Biochem J (1991) 0.85

Oleoyl-estrone induces the loss of body fat in rats. Int J Obes Relat Metab Disord (1996) 0.85

Whole-rat protein content estimation: applicability of the N x 6.25 factor. Br J Nutr (1994) 0.85